Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2007 2
2008 2
2009 3
2010 1
2012 5
2013 4
2014 5
2015 2
2016 4
2017 1
2018 5
2019 2
2020 6
2021 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
Eteläinen TS, Silva MC, Uhari-Väänänen JK, De Lorenzo F, Jäntti MH, Cui H, Chavero-Pieres M, Kilpeläinen T, Mechtler C, Svarcbahs R, Seppälä E, Savinainen JR, Puris E, Fricker G, Gynther M, Julku UH, Huttunen HJ, Haggarty SJ, Myöhänen TT. Eteläinen TS, et al. Among authors: huttunen hj. Sci Transl Med. 2023 Apr 12;15(691):eabq2915. doi: 10.1126/scitranslmed.abq2915. Epub 2023 Apr 12. Sci Transl Med. 2023. PMID: 37043557
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.
Huttunen HJ, Booms S, Sjögren M, Kerstens V, Johansson J, Holmnäs R, Koskinen J, Kulesskaya N, Fazio P, Woolley M, Brady A, Williams J, Johnson D, Dailami N, Gray W, Levo R, Saarma M, Halldin C, Marjamaa J, Resendiz-Nieves J, Grubor I, Lind G, Eerola-Rautio J, Mertsalmi T, Andréasson M, Paul G, Rinne J, Kivisaari R, Bjartmarz H, Almqvist P, Varrone A, Scheperjans F, Widner H, Svenningsson P. Huttunen HJ, et al. Mov Disord. 2023 Jul;38(7):1209-1222. doi: 10.1002/mds.29426. Epub 2023 May 22. Mov Disord. 2023. PMID: 37212361 Clinical Trial.
The Cell Biology of Tau Secretion.
Merezhko M, Uronen RL, Huttunen HJ. Merezhko M, et al. Among authors: huttunen hj. Front Mol Neurosci. 2020 Sep 23;13:569818. doi: 10.3389/fnmol.2020.569818. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33071756 Free PMC article. Review.
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
Barker RA, Björklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells AP, Fiandaca MS, Stoessl AJ, Eidelberg D, Federoff H, Voutilainen MH, Dexter DT, Eberling J, Brundin P, Isaacs L, Mursaleen L, Bresolin E, Carroll C, Coles A, Fiske B, Matthews H, Lungu C, Wyse RK, Stott S, Lang AE. Barker RA, et al. Among authors: huttunen hj. J Parkinsons Dis. 2020;10(3):875-891. doi: 10.3233/JPD-202004. J Parkinsons Dis. 2020. PMID: 32508331 Free PMC article. Review.
Mechanisms of secretion and spreading of pathological tau protein.
Brunello CA, Merezhko M, Uronen RL, Huttunen HJ. Brunello CA, et al. Among authors: huttunen hj. Cell Mol Life Sci. 2020 May;77(9):1721-1744. doi: 10.1007/s00018-019-03349-1. Epub 2019 Oct 30. Cell Mol Life Sci. 2020. PMID: 31667556 Free PMC article. Review.
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage.
Tseng KY, Stratoulias V, Hu WF, Wu JS, Wang V, Chen YH, Seelbach A, Huttunen HJ, Kulesskaya N, Pang CY, Chou JL, Lindahl M, Saarma M, Huang LC, Airavaara M, Liew HK. Tseng KY, et al. Among authors: huttunen hj. Cell Death Dis. 2023 Feb 15;14(2):128. doi: 10.1038/s41419-022-05520-2. Cell Death Dis. 2023. PMID: 36792604 Free PMC article.
CDNF Protein Therapy in Parkinson's Disease.
Huttunen HJ, Saarma M. Huttunen HJ, et al. Cell Transplant. 2019 Apr;28(4):349-366. doi: 10.1177/0963689719840290. Epub 2019 Apr 4. Cell Transplant. 2019. PMID: 30947516 Free PMC article.
ACAT as a drug target for Alzheimer's disease.
Huttunen HJ, Kovacs DM. Huttunen HJ, et al. Neurodegener Dis. 2008;5(3-4):212-4. doi: 10.1159/000113705. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322393 Free PMC article. Review.
48 results